Contrast Media/Contrast Agent Market

Contrast Media/Contrast Agent Market by Type (Iodinated, Gadolinium, Barium, and Microbubble), Procedure (X-Ray/CT, MRI, and Ultrasound), Application (Radiology, Interventional Radiology, and Interventional Cardiology), Region - Global Forecast to 2024

Report Code: MD 3577 Dec, 2019, by marketsandmarkets.com
COVID-19

Get in-depth analysis of how COVID-19 is impacting the Contrast Media/Contrast Agent Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Contrast Media/Contrast Agent Market

Request Now

[161 Pages Report] The global contrast media market size is expected to reach USD 6.0 billion by 2024 from an estimate of USD 5.0 billion in 2019, growing at a CAGR of 3.8% during the forecast period. Growth in the market can primarily be attributed to the increasing number of approvals of contrast agents, the rising volume of CT and MRI examinations globally, and the rapidly growing cancer and CVD population across the globe. Rising research activities on contrast agents & their applications are the key areas of opportunity in this market. On the other hand, factors such as side-effects & allergic reactions, as well as the adverse effects associated with contrast agents are expected to limit market growth to a certain extent.

Contrast Media Market

The iodinated contrast media segment is expected to command the largest contrast media market share in 2019

Based on type, the market is categorized into barium-based, iodinated contrast media, gadolinium-based, and microbubble-based contrast media. The iodinated contrast media segment is expected to command the largest share of the contrast media market in 2019. The high share of this segment can be attributed due to its high usage in CT examinations coupled with the fact that it can be used in almost all body parts.

Ultrasound modality is expected to register the highest growth during the forecast period

Based on modality, the market is segmented into X-ray/CT, MRI, and ultrasound procedures. In 2019, X-ray/CT procedures are expected to command the largest share of the global contrast media market. However, the ultrasound segment is expected to grow at the highest CAGR from 2019 to 2024. Growth in the ultrasound segment can largely be attributed to several advantages offered by ultrasound contrast agents over other contrast agents and the rising number of approvals for ultrasound contrast agents in the US, Europe, and Japan.

The cardiovascular disorders segment is expected to command the largest share during the forecast period

Based on indication, the market is categorized into cardiovascular disorders, cancer, gastrointestinal disorders, musculoskeletal disorders, neurological disorders, and nephrological disorders. The cardiovascular disorders segment is expected to command the largest share and highest growth rate during the forecast period. Improvements in cardiac MRI procedures in cath labs, favorable reimbursement policies for contrast media used in cardiovascular diagnosis, and robust healthcare infrastructure in developed countries are some of the factors driving this segment.

Intravascular route of administration is expected to register the highest growth during the forecast period

Based on the route of administration, the market is categorized into oral, intravascular, rectal, and other routes. The intravascular route segment is expected to command the largest share of the contrast media market in 2019. This segment is also expected to grow at the highest CAGR from 2019 to 2024. Growth in this segment can largely be attributed to advancements in CT and MRI imaging technologies that majorly use the intravascular route to inject contrast media.

Interventional cardiology is expected to register the highest growth during the forecast period

Based on the application, the market is segmented into radiology, interventional radiology, and interventional cardiology. In 2019, the radiology segment is expected to command the largest share of the global contrast media market. However, the interventional cardiology segment is expected to grow at the highest CAGR from 2019 to 2024. Growth in the interventional cardiology segment can largely be attributed to factors such increasing demand for minimally invasive surgical procedures across the globe and rising burden of cardiovascular diseases.

Contrast Media Market

North America accounted for the largest share of the contrast media/contrast agents market in 2018, while the Asia Pacific market is expected to register the highest growth during the forecast period

Geographically, the North American market is expected to account for the largest share of the global contrast media market. The Asia Pacific market is expected to grow at the highest CAGR in the forecast period. This growth can be attributed to the increasing R&D investments and favorable demographic scenario in China, rising aging population and cancer incidence in Japan, growing investments in the Indian radiology market, and growing focus of market players & increasing government support in other APAC countries.

Key Market Players

GE Healthcare (US), Bracco Imaging (Italy), Bayer HealthCare (Germany), and Guerbet (France) are some of the leading players in the contrast media market. Other prominent players in the market are Lantheus (US), Daiichi Sankyo (Japan), Unijules Life Sciences (India), J.B. Chemicals and Pharmaceuticals (India), Sanochemia (Austria) Taejoon Pharm (South Korea), Jodas (India), and Magnus Health (India).

Scope of the report

Report Metric

Details

Market size available for years

2018–2024

Base year considered

2018

Forecast period

2019–2024

Forecast unit

Value (USD)

Segments covered

Modality, Product, Application, Route of administration, Indications, and Region

Geographies covered

North America (US & Canada), Europe (Germany, France, the UK, Spain, Italy, and RoE), Asia Pacific (Japan, China, India, and RoAPAC) and the RoW (LATAM, MEA)

Companies covered

Major 10 players included, including GE Healthcare (US), Bayer (Germany), Bracco Imaging S.p.A (Italy), and Guerbet Group (France), Lantheus (US)

This research report categorizes the contrast media/contrast agents market based on modality, product, application, route of administration, indications, and region.

By Type

  • Barium-based Contrast media/contrast agents
  • Iodinated Contrast media/contrast agents
  • Gadolinium-based Contrast media/contrast agents
  • Microbubble Contrast media/contrast agents

By Modality

  • X-ray/Computed Tomography (CT)
  • Magnetic Resonance Imaging (MRI)
  • Ultrasound

By Route of Administration

  • Oral
  • Intravascular
  • Rectal
  • Other Routes

By Indication

  • Cardiovascular Disorders
  • Cancer
  • Gastrointestinal Disorders
  • Musculoskeletal Disorders
  • Neurological Disorders
  • Nephrological Disorders

By Application

  • Radiology
  • Interventional Radiology
  • Interventional Cardiology

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia Pacific
    • China
    • Japan
    • India
    • RoAPAC
  • Rest of the World (RoW)

Recent Developments:

  • In 2017, GE Healthcare (US) launched a new Macrocyclic MRI contrast agent, Clariscan, in Europe.
  • In 2019, Bayer AG (Germany)  received FDA approval for Gadavist as the first contrast agent for cardiac MRI.
  • In 2019, Guerbet Group partnered with IBM Watson Health for AI in medical imaging to support liver cancer diagnostics, utilizing CT and MRI imaging.

Key Questions Addressed by the Report

  • Which product segment will dominate the contrast media market in the future?
  • Which application segment will dominate the contrast media/contrast agents market in the future?
  • Emerging countries offer immense opportunities for the growth and adoption of contrast media; will this scenario continue in the coming five years?
  • Where will all the advancements in technology offered by various companies take the industry in the mid- to long-term?
  • What are the upcoming products in the contrast media market?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 19)
    1.1 Objectives of the Study
    1.2 Market Definition
           1.2.1 Markets Covered
           1.2.2 Years Considered for the Study
    1.3 Currency
    1.4 Limitations
    1.5 Stakeholders

2 Research Methodology (Page No. - 22)
    2.1 Research Data
           2.1.1 Secondary and Primary Research Methodology
                    2.1.1.1 Secondary Research
                    2.1.1.2 Primary Research
           2.1.2 Key Insights From Primary Sources
           2.1.3 Market Size Estimation Methodology
           2.1.4 Revenue Mapping-Based Market Estimation
           2.1.5 Market Data Validation and Triangulation
    2.2 Assumptions

3 Executive Summary (Page No. - 32)

4 Premium Insights (Page No. - 37)
    4.1 Contrast Media Market Overview
    4.2 European Contrast Media Market, By Modality (2019)
    4.3 Contrast Media Market Share, By Modality, 2019 vs. 2024
    4.4 Contrast Media Market Share, By Route of Administration, 2019 vs. 2024
    4.5 Contrast Media Market Share, By Indication, 2019 vs. 2024
    4.6 Contrast Media Market Share, By Application, 2019 vs. 2024
    4.7 Contrast Media Market Share, By Type, 2019 vs. 2024
    4.8 Geographic Snapshot: Contrast Media Market

5 Market Overview (Page No. - 42)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Increasing Prevalence of Cancer and Cvds
                    5.2.1.2 Approvals of Contrast Agents
                    5.2.1.3 Increasing Demand for Early Diagnosis and Rising Volume of Ct and Mri Examinations
           5.2.2 Restraints
                    5.2.2.1 Side-Effects and Allergic Reactions Associated With Contrast Agents
           5.2.3 Opportunities
                    5.2.3.1 Generic Contrast Media
                    5.2.3.2 Increasing Research
           5.2.4 Challenges
                    5.2.4.1 Technological Advancements in Imaging Solutions
                    5.2.4.2 Restriction and Withdrawal of Linear Gadolinium-Based Contrast Agents

6 Contrast Media/Contrast Agents Market, By Type (Page No. - 48)
    6.1 Introduction
    6.2 Iodinated Contrast Media
           6.2.1 Extensive Usage of Iodinated Contrast Media in Ct Examinations is A Key Factor Supporting Market Growth
    6.3 Gadolinium-Based Contrast Media
           6.3.1 APAC is the Fastest-Growing Market for Gadolinium-Based Contrast Media
    6.4 Microbubble Contrast Media
           6.4.1 Microbubble Contrast Media to Register the Highest Growth Rate During the Forecast Period
    6.5 Barium-Based Contrast Media
           6.5.1 Barium-Based Contrast Media Can Cause Adverse Effects in Patients, Owing to Which the Market is Projected to Decline

7 Contrast Media/Contrast Agents Market, By Modality (Page No. - 53)
    7.1 Introduction
    7.2 X-Ray/Ct
           7.2.1 X-Ray/Ct Accounts For The Largest Share of the Contrast Media Market
    7.3 Magnetic Resonance Imaging
           7.3.1 Growing Number of Mri Scanners and Increasing Mri Examinations are Likely to Drive Market Growth
    7.4 Ultrasound
           7.4.1 Ultrasound Contrast Agents Will Register the Highest Growth Rate During the Forecast Period

8 Contrast Media/Contrast Agents Market, By Indication (Page No. - 59)
    8.1 Introduction
    8.2 Cardiovascular Diseases
           8.2.1 Cardiovascular Diseases Segment to Dominate the Contrast Media Market
    8.3 Cancer
           8.3.1 Asia Pacific is Expected to Register Relatively Higher Growth Owing to the High Cancer Prevalence in the Region
    8.4 Gastrointestinal Disorders
           8.4.1 Rising Prevalence of Gi Disorders to Support Market Growth
    8.5 Musculoskeletal Disorders
           8.5.1 Rising Incidence of Work-Related Musculoskeletal Disorders to Support Market Growth
    8.6 Neurological Disorders
           8.6.1 Rising Prevalence of Dementia Worldwide to Support Market Growth
    8.7 Nephrological Disorders
           8.7.1 Rising Prevalence of Esrd is Driving the Demand for Diagnostic Tools for Kidney Diseases

9 Contrast Media/Contrast Agents Market, By Route of Administration (Page No. - 66)
    9.1 Introduction
    9.2 Intravascular Route
           9.2.1 Intravascular Route of Administration is Expected to Grow at the Highest CAGR During the Forecast Period
                    9.2.1.1 Intravenous (IV)
                    9.2.1.2 Intra-Arterial (IA)
    9.3 Oral Route
           9.3.1 North America to Dominate the Contrast Media Market for Oral Route of Administration
    9.4 Rectal Route
           9.4.1 Contrast Agents Administered Rectally are Liquid E-Z-Paque, Liquid Polibar Plus, and Micropaque
    9.5 Other Routes of Administration

10 Contrast Media/Contrast Agents Market, By Application (Page No. - 71)
     10.1 Introduction
     10.2 Radiology
             10.2.1 Growing Number of Diagnostic Procedures to Drive the Contrast Media Market for Radiology Applications
     10.3 Interventional Radiology
             10.3.1 Increasing Popularity of Minimally Invasive Procedures to Support Market Growth
     10.4 Interventional Cardiology
             10.4.1 Rising Incidence of Cardiac Disorders to Drive the Demand for Interventional Cardiology Procedures

11 Contrast Media/Contrast Agents Market, By Region (Page No. - 76)
     11.1 Introduction
     11.2 North America
             11.2.1 US
                        11.2.1.1 The US Dominates the Global Contrast Media Market
             11.2.2 Canada
                        11.2.2.1 Increasing Investments in Improving Medical Imaging—A Major Factor Driving Market Growth in Canada
     11.3 Europe
             11.3.1 Germany
                        11.3.1.1 Presence of A Well-Developed Diagnostic Imaging Infrastructure is A Major Factor Supporting Market Growth in Germany
             11.3.2 France
                        11.3.2.1 Increasing Prevalence of Cancer Will Drive the Market for Contrast Media in France
                        11.3.3.1 Increasing Investments in the Field of Diagnostic Imaging to Boost Market Growth
             11.3.4 Italy
                        11.3.4.1 Growing Prevalence of Cancer and Obesity Will Drive the Demand for Diagnostic Procedures in Italy
             11.3.5 Spain
                        11.3.5.1 Shortage of Radiologists in the Country to Restrain Market Growth
             11.3.6 Rest of Europe
     11.4 Asia Pacific
             11.4.1 Japan
                        11.4.1.1 Japan Dominates the APAC Contrast Media Market
             11.4.2 China
                        11.4.2.1 High Incidence of Cancer and Strokes Will Support the Market for Contrast Media in China
             11.4.3 India
                        11.4.3.1 Growing Investments in the Indian Radiology Market Will Propel Market Growth
             11.4.4 Rest of Asia Pacific
     11.5 Rest of the World

12 Competitive Landscape (Page No. - 115)
     12.1 Introduction
     12.2 Market Share Analysis
     12.3 Right-To-Win
     12.4 Competitive Leadership Mapping
             12.4.1 Visionary Leaders
             12.4.2 Innovators
             12.4.3 Dynamic Differentiators
             12.4.4 Emerging Companies
     12.5 Competitive Scenario
             12.5.1 Product Launches & Approvals
             12.5.2 Expansions
             12.5.3 Acquisitions
             12.5.4 Partnerships & Agreements

13 Company Profiles (Page No. - 123)
(Business Overview, Products Offered, Recent Developments, and Mnm View)* 
     13.1 GE Healthcare
     13.2 Bracco Imaging S.P.A
     13.3 Bayer AG
     13.4 Guerbet Group
     13.5 Lantheus Medical Imaging, Inc.
     13.6 Daiichi Sankyo
     13.7 Unijules Life Sciences
     13.8 J.B. Chemicals and Pharmaceuticals Ltd.
     13.9 Sanochemia
     13.10 Magnus Health
     13.11 Taejoon Pharm
     13.12 Jodas Expoim
     13.13 Nano Therapeutics Pvt. Ltd.
     13.14 Kiran X-Ray
     13.15 Interpharma Praha A.S.
     13.16 Imax Diagnostic Imaging Limited
     13.17 Yangtze River Pharmaceutical Group (YRPG)
     13.18 Spago Nanomedical AB
     13.19 Subhra Pharma Pvt. Ltd.
     13.20 M. Biotech Limited
     13.21 Mri Contrast Agents: Product Comparison
     13.22 CT Contrast Agents: Product Comparison
     13.23 Ultrasound Contrast Agents: Product Comparison
*Details on Business Overview, Products Offered, Recent Developments, and Mnm View Might Not Be Captured in Case of Unlisted Companies. 

14 Appendix (Page No. - 157)
     14.1 Discussion Guide
     14.2 Available Customizations
     14.3 Related Reports
     14.4 Author Details


List of Tables (121 Tables)

Table 1 List of Side-Effects/Reactions to Contrast Media, By Type
Table 2 Indicative List of Research Studies
Table 3 Contrast Media Market, By Type, 2017–2024 (USD Million)
Table 4 Iodinated Contrast Media Market, By Region, 2017–2024 (USD Million)
Table 5 Gadolinium-Based Contrast Media Market, By Region, 2017–2024 (USD Million)
Table 6 Microbubble Contrast Media Market, By Region, 2017–2024 (USD Million)
Table 7 Barium-Based Contrast Media Market, By Region, 2017–2024 (USD Million)
Table 8 Contrast Media Market, By Modality, 2017–2024 (USD Million)
Table 9 Installed Base of CT Scanners, By Region, 2017 vs. 2018
Table 10 Increase in CT Procedural Volumes, By Region, 2017 vs. 2018 (Million)
Table 11 X-Ray/CT Contrast Media Market, By Region, 2017–2024 (USD Million)
Table 12 Installed Base of Mri Systems, By Region, 2017 vs. 2018
Table 13 Increase in Mri Procedural Volumes, By Region, 2017 vs. 2018 (Million)
Table 14 Mri Contrast Media Market, By Region, 2017–2024 (USD Million)
Table 15 Ultrasound Contrast Media Market, By Region, 2017–2024 (USD Million)
Table 16 Contrast Media Market, By Indication, 2017–2024 (USD Million)
Table 17 Contrast Media Market for Cardiovascular Diseases, By Region, 2017–2024 (USD Million)
Table 18 Contrast Media Market for Cancer, By Region, 2017–2024 (USD Million)
Table 19 Contrast Media Market for Gastrointestinal Disorders, By Region, 2017–2024 (USD Million)
Table 20 Contrast Media Market for Musculoskeletal Disorders,By Region, 2017–2024 (USD Million)
Table 21 Contrast Media Market for Neurological Disorders, By Region, 2017–2024 (USD Million)
Table 22 Contrast Media Market for Nephrological Disorders, By Region, 2017–2024 (USD Million)
Table 23 Contrast Media Market, By Route of Administration, 2017–2024 (USD Million)
Table 24 Contrast Media Market for Intravascular Route of Administration, By Region, 2017–2024 (USD Million)
Table 25 Contrast Media Market for Oral Route of Administration, By Region, 2017–2024 (USD Million)
Table 26 Contrast Media Market for Rectal Route of Administration, By Region, 2017–2024 (USD Million)
Table 27 Contrast Media Market for Other Routes of Administration, By Region, 2017–2024 (USD Million)
Table 28 Contrast Media Market, By Application, 2017–2024 (USD Million)
Table 29 Contrast Media Market for Radiology Applications, By Region,2017–2024 (USD Million)
Table 30 Contrast Media Market for Interventional Radiology Applications, By Region, 2017–2024 (USD Million)
Table 31 Contrast Media Market for Interventional Cardiology Applications, By Region, 2017–2024 (USD Million)
Table 32 Contrast-Enhanced CT Procedural Volume, By Region, 2017 vs. 2018 (Million)
Table 33 Contrast-Enhanced Mri Procedural Volume, By Region, 2017 vs. 2018 (Million)
Table 34 Contrast Media Market, By Region, 2017–2024 (USD Million)
Table 35 North America: Contrast Media Market, By Country, 2017–2024 (USD Million)
Table 36 North America: Contrast Media Market, By Modality, 2017–2024 (USD Million)
Table 37 North America: Contrast Media Market, By Type, 2017–2024 (USD Million)
Table 38 North America: Contrast Media Market, By Route of Administration, 2017–2024 (USD Million)
Table 39 North America: Contrast Media Market, By Indication, 2017–2024 (USD Million)
Table 40 North America: Contrast Media Market, By Application, 2017–2024 (USD Million)
Table 41 US: Contrast Media Market, By Modality, 2017–2024 (USD Million)
Table 42 US: Contrast Media Market, By Type, 2017–2024 (USD Million)
Table 43 US: Contrast Media Market, By Route of Administration, 2017–2024 (USD Million)
Table 44 US: Contrast Media Market, By Indication, 2017–2024 (USD Million)
Table 45 US: Contrast Media Market, By Application, 2017–2024 (USD Million)
Table 46 Canada: Contrast Media Market, By Modality, 2017–2024 (USD Million)
Table 47 Canada: Contrast Media Market, By Type, 2017–2024 (USD Million)
Table 48 Canada: Contrast Media Market, By Route of Administration, 2017–2024 (USD Million)
Table 49 Canada: Contrast Media Market, By Indication, 2017–2024 (USD Million)
Table 50 Canada: Contrast Media Market, By Application, 2017–2024 (USD Million)
Table 51 Europe: Contrast Media Market, By Country, 2017–2024 (USD Million)
Table 52 Europe: Contrast Media Market, By Modality, 2017–2024 (USD Million)
Table 53 Europe: Contrast Media Market, By Type, 2017–2024 (USD Million)
Table 54 Europe: Contrast Media Market, By Route of Administration, 2017–2024 (USD Million)
Table 55 Europe: Contrast Media Market, By Indication, 2017–2024 (USD Million)
Table 56 Europe: Contrast Media Market, By Application, 2017–2024 (USD Million)
Table 57 Germany: Contrast Media Market, By Modality, 2017–2024 (USD Million)
Table 58 Germany: Contrast Media Market, By Type, 2017–2024 (USD Million)
Table 59 Germany: Contrast Media Market, By Route of Administration, 2017–2024 (USD Million)
Table 60 Germany: Contrast Media Market, By Indication, 2017–2024 (USD Million)
Table 61 Germany: Contrast Media Market, By Application, 2017–2024 (USD Million)
Table 62 France: Contrast Media Market, By Modality, 2017–2024 (USD Million)
Table 63 France: Contrast Media Market, By Type, 2017–2024 (USD Million)
Table 64 France: Contrast Media Market, By Route of Administration, 2017–2024 (USD Million)
Table 65 France: Contrast Media Market, By Indication, 2017–2024 (USD Million)
Table 66 France: Contrast Media Market, By Application, 2017–2024 (USD Million)
Table 67 UK: Contrast Media Market, By Modality, 2017–2024 (USD Million)
Table 68 UK: Contrast Media Market, By Type, 2017–2024 (USD Million)
Table 69 UK: Contrast Media Market, By Route of Administration, 2017–2024 (USD Million)
Table 70 UK: Contrast Media Market, By Indication, 2017–2024 (USD Million)
Table 71 UK: Contrast Media Market, By Application, 2017–2024 (USD Million)
Table 72 Italy: Contrast Media Market, By Modality, 2017–2024 (USD Million)
Table 73 Italy: Contrast Media Market, By Type, 2017–2024 (USD Million)
Table 74 Italy: Contrast Media Market, By Route of Administration, 2017–2024 (USD Million)
Table 75 Italy: Contrast Media Market, By Indication, 2017–2024 (USD Million)
Table 76 Italy: Contrast Media Market, By Application, 2017–2024 (USD Million)
Table 77 Spain: Contrast Media Market, By Modality, 2017–2024 (USD Million)
Table 78 Spain: Contrast Media Market, By Type, 2017–2024 (USD Million)
Table 79 Spain: Contrast Media Market, By Route of Administration, 2017–2024 (USD Million)
Table 80 Spain: Contrast Media Market, By Indication, 2017–2024 (USD Million)
Table 81 Spain: Contrast Media Market, By Application, 2017–2024 (USD Million)
Table 82 RoE: Contrast Media Market, By Modality, 2017–2024 (USD Million)
Table 83 RoE: Contrast Media Market, By Type, 2017–2024 (USD Million)
Table 84 RoE: Contrast Media Market, By Route of Administration, 2017–2024 (USD Million)
Table 85 RoE: Contrast Media Market, By Indication, 2017–2024 (USD Million)
Table 86 RoE: Contrast Media Market, By Application, 2017–2024 (USD Million)
Table 87 APAC: Contrast Media Market, By Country, 2017–2024 (USD Million)
Table 88 APAC: Contrast Media Market, By Modality, 2017–2024 (USD Million)
Table 89 APAC: Contrast Media Market, By Type, 2017–2024 (USD Million)
Table 90 APAC: Contrast Media Market, By Route of Administration, 2017–2024 (USD Million)
Table 91 APAC: Contrast Media Market, By Indication, 2017–2024 (USD Million)
Table 92 APAC: Contrast Media Market, By Application, 2017–2024 (USD Million)
Table 93 Japan: Contrast Media Market, By Modality, 2017–2024 (USD Million)
Table 94 Japan: Contrast Media Market, By Type, 2017–2024 (USD Million)
Table 95 Japan: Contrast Media Market, By Route of Administration, 2017–2024 (USD Million)
Table 96 Japan: Contrast Media Market, By Indication, 2017–2024 (USD Million)
Table 97 Japan: Contrast Media Market, By Application, 2017–2024 (USD Million)
Table 98 China: Contrast Media Market, By Modality, 2017–2024 (USD Million)
Table 99 China: Contrast Media Market, By Type, 2017–2024 (USD Million)
Table 100 China: Contrast Media Market, By Route of Administration, 2017–2024 (USD Million)
Table 101 China: Contrast Media Market, By Indication, 2017–2024 (USD Million)
Table 102 China: Contrast Media Market, By Application, 2017–2024 (USD Million)
Table 103 India: Contrast Media Market, By Modality, 2017–2024 (USD Million)
Table 104 India: Contrast Media Market, By Type, 2017–2024 (USD Million)
Table 105 India: Contrast Media Market, By Route of Administration, 2017–2024 (USD Million)
Table 106 India: Contrast Media Market, By Indication, 2017–2024 (USD Million)
Table 107 India: Contrast Media Market, By Application, 2017–2024 (USD Million)
Table 108 RoAPAC: Contrast Media Market, By Modality, 2017–2024 (USD Million)
Table 109 RoAPAC: Contrast Media Market, By Type, 2017–2024 (USD Million)
Table 110 RoAPAC: Contrast Media Market, By Route of Administration, 2017–2024 (USD Million)
Table 111 RoAPAC: Contrast Media Market, By Indication, 2017–2024 (USD Million)
Table 112 RoAPAC: Contrast Media Market, By Application,2017–2024 (USD Million)
Table 113 RoW: Contrast Media Market, By Modality, 2017–2024 (USD Million)
Table 114 RoW: Contrast Media Market, By Type, 2017–2024 (USD Million)
Table 115 RoW: Contrast Media Market, By Route of Administration, 2017–2024 (USD Million)
Table 116 RoW: Contrast Media Market, By Indication, 2017–2024 (USD Million)
Table 117 RoW: Contrast Media Market, By Application, 2017–2024 (USD Million)
Table 118 Product Launches & Approvals (2016–2019)
Table 119 Expansions (2016–2019)
Table 120 Acquisitions (2016–2019)
Table 121 Partnerships & Agreements (2016–2019)


List of Figures (36 Figures)

Figure 1 Research Methodology Steps: Contrast Media Market
Figure 2 Research Design
Figure 3 Key Data From Secondary Sources
Figure 4 Breakdown of Primary Interviews: By Company Type,Designation, and Region
Figure 5 Key Data From Primary Sources
Figure 6 Research Methodology: Hypothesis Building
Figure 7 Data Triangulation Methodology
Figure 8 Contrast Media Market, By Modality, 2019 vs. 2024 (USD Million)
Figure 9 Contrast Media Market, By Route of Administration, 2019 vs. 2024 (USD Million)
Figure 10 Contrast Media Market, By Indication, 2019 vs. 2024 (USD Million)
Figure 11 Contrast Media Market, By Application, 2019 vs. 2024 (USD Million)
Figure 12 Contrast Media Market, By Type, 2019 vs. 2024 (USD Million)
Figure 13 Asia Pacific is Slated to Witness the Highest Growth in the Contrast Media Market During the Forecast Period
Figure 14 Growing Volume of CT and Mri Examinations Will Drive the Growth of the Contrast Media Market
Figure 15 Germany Accounts for the Largest Share of the Contrast Media Market in Europe
Figure 16 X-Ray/CT Will Continue to Dominate the Contrast Media Market, By Modality, in 2024
Figure 17 Intravascular Route Accounts for the Largest Share of the Market
Figure 18 Cardiovascular Diseases to Account for the Largest Share of the Contrast Media Market in 2024
Figure 19 Radiology Commands the Largest Share of the Contrast Media Market
Figure 20 Iodinated Contrast Media Account for the Largest Share of the Contrast Media Market, By Type
Figure 21 APAC to Witness Highest Growth During the Forecast Period
Figure 22 Contrast Media Market: Drivers, Restraints, Opportunities, and Challenges
Figure 23 North America Will Continue to Dominate the Contrast Media Market in 2024
Figure 24 North America: Contrast Media Market Snapshot
Figure 25 Asia Pacific: Contrast Media Market Snapshot
Figure 26 Key Developments in the Contrast Media Market, 2016–2019
Figure 27 Contrast Media Market Share, By Key Player, 2018
Figure 28 Contrast Media Market: Competitive Leadership Mapping, 2018
Figure 29 GE Healthcare: Company Snapshot (2018)
Figure 30 Bracco Imaging S.P.A: Company Snapshot (2018)
Figure 31 Bayer Ag: Company Snapshot (2018)
Figure 32 Guerbet Group: Company Snapshot (2018)
Figure 33 Lantheus: Company Snapshot (2018)
Figure 34 Daiichi Sankyo: Company Snapshot (2018)
Figure 35 J.B. Chemicals & Pharmaceuticals: Company Snapshot (2018)
Figure 36 Sanochemia: Company Snapshot (2018)

The study involved four major activities in estimating the current size for contrast media/contrast agents market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.

Secondary Research

In the secondary research process, various secondary sources such as D&B Hoovers, Bloomberg Business, and Factiva have been referred to, to identify and collect information for the contrast media/contrast agents market study. These secondary sources included annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold standard & silver standard websites, regulatory bodies, and databases.

Primary Research

The contrast media/contrast agents market comprises several stakeholders such as contrast media/contrast agents manufacturers and distributors, healthcare institutions (hospitals, medical schools, group practices, individual surgeons, and governing bodies), medical device vendors/service providers, research institutes, and research and consulting firms. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. Mentioned below is the breakdown of primary respondents:

Contrast Media Market

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the contrast media/contrast agents market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and markets have been identified through extensive secondary research
  • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Data Triangulation

After arriving at the overall contrast media/contrast agents market size-using the market size estimation processes as explained above-the market was split into several segments and subsegments. To complete the overall market engineering process and to arrive at the exact statistics of each market segment and subsegment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the contrast media/contrast agents industry

Report Objectives

  • To define, describe, and measure the Contrast media/contrast agents  market by product, application, end-user, and region
  • To provide detailed information about the significant factors influencing contrast media/contrast agents market growth (such as drivers, restraints, growth opportunities, and challenges)
  • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the Contrast media/contrast agents  market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the market in North America, Europe, Asia Pacific (APAC), and the Rest of the World (RoW)
  • To strategically analyze the market structure and profile key players and their core competencies in the Contrast media/contrast agents market

To track and analyze competitive developments such as product launches, expansions, acquisitions, partnerships, and collaborations in the Contrast media/contrast agents market.

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the Contrast media/contrast agents market report:

Product Analysis

  • Product matrix, which gives a detailed comparison of the software portfolios of the top five companies

Company Information

  • Detailed analysis and profiling of additional market players (up to 5)
Report Code
MD 3577
Published ON
Dec, 2019
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Contrast Media/Contrast Agent Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home